Contact

All Stories

  1. Response to Letter to the Editors regarding article entitled ‘Sex-related patient-reported brain fog symptoms in nonhospitalised COVID-19 patients’

    Article • Neurologia i Neurochirurgia Polska, May 2023, VM Media SP. zo.o VM Group SK

    Leszek Drabik

  2. Course of fatigue among patients previously hospitalised due to COVID-19

    Article • Neurologia i Neurochirurgia Polska, February 2023, VM Media SP. zo.o VM Group SK

    Leszek Drabik

  3. Sex-related patient-reported brain fog symptoms in non-hospitalised COVID-19 patients

    Article • Neurologia i Neurochirurgia Polska, February 2023, VM Media SP. zo.o VM Group SK

    Leszek Drabik

  4. SARS-CoV-2 infection and SLE: endothelial dysfunction, atherosclerosis, and thrombosis

    Article • Clinical Rheumatology, January 2023, Springer Science + Business Media

    Leszek Drabik

  5. Fatigue after COVID‐19 in non‐hospitalized patients according to sex

    Article • Brain and Behavior, January 2023, Wiley

    Leszek Drabik

  6. MicroRNA composition of plasma extracellular vesicles: a harbinger of late cardiotoxicity of doxorubicin

    Article • Molecular Medicine, December 2022, Springer Science + Business Media

    Leszek Drabik

  7. Brain Fog and Quality of Life at Work in Non-Hospitalized Patients after COVID-19

    Article • International Journal of Environmental Research and Public Health, October 2022, MDPI AG

    Leszek Drabik

  8. Arterial stiffness and atherosclerosis in systemic lupus erythematosus patients

    Article • Reumatologia/Rheumatology, July 2022, Termedia Sp. z.o.o.

    Leszek Drabik

  9. Neurological Prognostic Factors in Hospitalized Patients with COVID-19

    Article • Brain Sciences, January 2022, MDPI AG

    Leszek Drabik

  10. Prognostic significance of age in patients with acute ischaemic stroke treated with intravenous thrombolysis

    Article • Neurologia i Neurochirurgia Polska, January 2022, VM Media SP. zo.o VM Group SK

    Leszek Drabik

  11. Acute myocardial infarction reparation/regeneration strategy using Wharton’s jelly multipotent stem cells as an ‘unlimited’ therapeutic agent: 3-year outcomes in a pilot cohort of the CIRCULATE-AMI trial

    Article • Advances in Interventional Cardiology, January 2022, Termedia Sp. z.o.o.

    Leszek Drabik

  12. Eligible-and-enrolled vs. eligible-but-not-enrolled patients with chronic ischaemic heart failure in randomized clinical trials of myocardial regeneration

    Article • Advances in Interventional Cardiology, January 2022, Termedia Sp. z.o.o.

    Leszek Drabik

  13. Endomyocardial transplantation of progenitor cells and risk of transient left ventricular systolic dysfunction

    Article • Advances in Interventional Cardiology, January 2022, Termedia Sp. z.o.o.

    Leszek Drabik

  14. Multi-modality imaging in the CIRCULATE-AMI pilot study cohort: a framework for an imaging-based randomized controlled trial of Wharton jelly mesenchymal stem cell use to stimulate myocardial repair/regeneration

    Article • Advances in Interventional Cardiology, January 2022, Termedia Sp. z.o.o.

    Leszek Drabik

  15. Objective, observer-independent evaluation of myocardial perfusion and function: the role of SPECT

    Article • Advances in Interventional Cardiology, January 2022, Termedia Sp. z.o.o.

    Leszek Drabik

  16. Clinical characteristics and medical therapy in randomized clinical trial eligible-and-enrolled vs. eligible-but-not enrolled patients with ischaemic heart failure

    Article • European Heart Journal, October 2021, Oxford University Press (OUP)

    Leszek Drabik

  17. Relationship between left ventricular global longitudinal strain, infarct size and left ventricular function in patients with acute myocardial infarction in a stem cell therapy study

    Article • European Heart Journal, October 2021, Oxford University Press (OUP)

    Leszek Drabik

  18. MicroRNA composition of plasma extracellular vesicles: a harbinger of late cardiotoxicity in long-term survivors of acute lymphoblastic leukemia treated with doxorubicin

    Article • September 2021, Research Square

    Leszek Drabik

  19. Fasting Normoglycemia after Intravenous Thrombolysis Predicts Favorable Long-Term Outcome in Non-Diabetic Patients with Acute Ischemic Stroke

    Article • Journal of Clinical Medicine, July 2021, MDPI AG

    Leszek Drabik

  20. Unsolved issues of The Efficacy and Safety of Edoxaban

    Article • June 2021, AVES Publishing Co.

    Leszek Drabik

  21. Neurological symptoms in hospitalised patients with COVID-19 and their association with in-hospital mortality

    Article • Neurologia i Neurochirurgia Polska, May 2021, VM Media SP. zo.o VM Group SK

    Leszek Drabik

  22. NRF2-related transcriptomic alterations as a long-term effect of doxorubicin treatment for childhood acute lymphoblastic leukemia

    Article • April 2021, Research Square

    Leszek Drabik

  23. C-Reactive Protein and White Blood Cell Count in Non-Infective Acute Ischemic Stroke Patients Treated with Intravenous Thrombolysis

    Article • Journal of Clinical Medicine, April 2021, MDPI AG

    Leszek Drabik

  24. Increased Levels of Platelets and Endothelial-Derived Microparticles in Patients With Non-Valvular Atrial Fibrillation During Rivaroxaban Therapy

    Article • Clinical and Applied Thrombosis/Hemostasis, January 2021, SAGE Publications

    Leszek Drabik

  25. Olfactory Dysfunction in Patients With Relapsing-Remitting Multiple Sclerosis Treated With Disease-Modifying Therapies

    Article • Ear Nose & Throat Journal, November 2020, SAGE Publications

    Leszek Drabik

  26. Evolution of left ventricular function after Wharton's jelly mesenchymal stem cells transcoronary administration: 5-year follow up in a pilot cohort of CIRCULATE-AMI Randomized Trial

    Article • European Heart Journal, November 2020, Oxford University Press (OUP)

    Leszek Drabik

  27. Fasting Hyperglycemia and Long-term Outcome in Patients with Acute Ischemic Stroke Treated with Mechanical Thrombectomy

    Article • Journal of Stroke and Cerebrovascular Diseases, May 2020, Elsevier

    Leszek Drabik

  28. Bleeding in anticoagulated patients with atrial fibrillation: practical considerations

    Article • Kardiologia Polska, February 2020, Polskie Towarzystwo Kardiologiczne

    Leszek Drabik

  29. Bleeding in anticoagulated patients with AF: practical considerations

    Article • Polish Archives of Internal Medicine, January 2020, Towarzystwo Internistow Polskich/Polish Society of Internal Medicine

    Leszek Drabik

  30. Flow Cytometric Assessment of Endothelial and Platelet Microparticles in Patients With Atrial Fibrillation Treated With Dabigatran

    Article • Clinical and Applied Thrombosis/Hemostasis, January 2020, SAGE Publications

    Leszek Drabik

  31. Antithrombotic therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention

    Article • Cardiologia Hungarica, January 2020, Cardiologia Hungarica

    Leszek Drabik

  32. The ORBIT bleeding score is associated with lysis and permeability of fibrin clots Address

    Article • Kardiologia Polska, October 2019, Polskie Towarzystwo Kardiologiczne

    Leszek Drabik

  33. Comparison of ECHO, SPECT and MRI in assessment of left ventricular function in AMI and CHF

    Article • European Heart Journal, October 2019, Oxford University Press (OUP)

    Leszek Drabik

  34. P774Transcoronary transfer of Wharton's jelly mesenchymal pluripotent stem cells in patients with chronic ischaemic heart failure shows safety and unprecedented high-grade myocardial uptake

    Article • European Heart Journal, October 2019, Oxford University Press (OUP)

    Leszek Drabik

  35. P4604Insights into left ventricular remodelling and clinical outcomes after Wharton's jelly multipotent stem cells transcoronary administration in a pilot cohort of CIRCULATE-AMI Trial (NCT03404063)

    Article • European Heart Journal, October 2019, Oxford University Press (OUP)

    Leszek Drabik

  36. Assessment of Left Atrial Function in Patients with Paroxysmal, Persistent, and Permanent Atrial Fibrillation Using Two-Dimensional Strain.

    Article • Journal of Atrial Fibrillation, October 2019, Cardiofront, LLC

    Leszek Drabik

  37. Clot Lysis Time Predicts Stroke During Anticoagulant Therapy in Patients with Atrial Fibrillation

    Article • Canadian Journal of Cardiology, August 2019, Elsevier

    Leszek Drabik

  38. NOAC, cancer and atrial fibrillation

    Article • The Anatolian Journal of Cardiology, January 2019, Kare Publishing

    Leszek Drabik

  39. Proportion of ischemic and non-ischemic (neurogenic) systolic dysfunction in myocardial infarction

    Article • Medical Science Monitor, June 2018, International Scientific Literature

    Leszek Drabik

  40. Clot permeability and risk of stroke and bleeding in atrial fibrillation.

    Article • Stroke, September 2017, Wolters Kluwer Health

    Leszek Drabik

  41. Risk of stroke and bleeding in patients with atrial fibrillation on VKA and fibrin clot permeability

    Article • European Heart Journal, August 2017, Oxford University Press (OUP)

    Leszek Drabik

  42. High regenerative cell (Wharton’s jelly) uptake in the myocardial infarct zone

    Article • European Heart Journal, August 2017, Oxford University Press (OUP)

    Leszek Drabik

  43. Biventricular outflow tract obstruction in adult male.

    Article • Journal of Rare Cardiovascular Diseases, January 2017, SoftQ Sp. z.o.o.

    Leszek Drabik

  44. Left ventricular aneurysm and ischemic mitral regurgitation - pathophysiology and treatment

    Article • Journal of Rare Cardiovascular Diseases, January 2017, SoftQ Sp. z.o.o.

    Leszek Drabik

  45. CHART-1 clinical trial

    Article • European Heart Journal, December 2016, European Society of Cardiology

    Leszek Drabik

  46. Myocardial infarction is associated with CCR7 polymorphism

    Article • International Journal of Immunogenetics, June 2016, Wiley

    Leszek Drabik

  47. Fibrin clot permeability in atrial fibrillation

    Article • Thrombosis Research, August 2015, Elsevier

    Leszek Drabik

  48. End‑stage constrictive pericarditis

    Article • Journal of Rare Cardiovascular Diseases, January 2015, SoftQ Sp. z.o.o.

    Leszek Drabik

  49. Systolic and diastolic function in adult Fontan patient

    Article • Acta Cardiologica, April 2014, Taylor & Francis

    Leszek Drabik

  50. Long‑term complications after Tetralogy of Fallot repair

    Article • Journal of Rare Cardiovascular Diseases, January 2014, SoftQ Sp. z.o.o.

    Leszek Drabik

  51. Tetralogy of Fallot with coronary artery anomaly

    Article • Journal of Rare Cardiovascular Diseases, January 2014, SoftQ Sp. z.o.o.

    Leszek Drabik

  52. Fungal endocardotis complicating idiopathic pulmonary arterial hypertension

    Article • Journal of Rare Cardiovascular Diseases, January 2013, SoftQ Sp. z.o.o.

    Leszek Drabik

  53. Patient with PAPVC (Scimitar syndrome).

    Article • Journal of Rare Cardiovascular Diseases, January 2013, SoftQ Sp. z.o.o.

    Leszek Drabik